Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$0.52 - $13.88 $296 - $7,911
-570 Closed
0 $0
Q4 2023

Feb 12, 2024

SELL
$0.35 - $0.53 $175 - $265
-500 Reduced 46.73%
570 $329,000
Q4 2022

Nov 13, 2023

SELL
$1.41 - $2.5 $606 - $1,075
-430 Reduced 28.67%
1,070 $1.63 Million
Q3 2022

Nov 13, 2023

BUY
$1.66 - $2.79 $830 - $1,395
500 Added 50.0%
1,500 $2.88 Million
Q1 2022

Nov 13, 2023

SELL
$2.97 - $5.2 $19,156 - $33,540
-6,450 Reduced 86.58%
1,000 $3.79 Million
Q4 2021

Nov 13, 2023

BUY
$4.99 - $7.46 $37,175 - $55,577
7,450 New
7,450 $37.4 Million

Others Institutions Holding INO

About INOVIO PHARMACEUTICALS, INC.


  • Ticker INO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 249,400,000
  • Market Cap $521M
  • Description
  • Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...
More about INO
Track This Portfolio

Track Td Waterhouse Canada Inc. Portfolio

Follow Td Waterhouse Canada Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Waterhouse Canada Inc., based on Form 13F filings with the SEC.

News

Stay updated on Td Waterhouse Canada Inc. with notifications on news.